ITLN1 and colorectal cancer: For instance, prospective cohort trials examining ITLN1 expression in gastric cancer, hepatocellular carcinoma, and colorectal cancer using standardized immunohistochemical protocols are essential for ensuring reproducible and clinically meaningful results.